In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...